Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003559
Accepted
2024-11-25 00:15:08
Documents
1
Effectiveness Date
2024-11-22
Registration Form
S-3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 600
  Complete submission text file 9999999995-24-003559.txt   1777
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283162 | Film No.: 241491744
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)